YU97673A - Process for obtaining substituted 3,4-dihydroxy-beta-phenetyl amines - Google Patents

Process for obtaining substituted 3,4-dihydroxy-beta-phenetyl amines

Info

Publication number
YU97673A
YU97673A YU00976/73A YU97673A YU97673A YU 97673 A YU97673 A YU 97673A YU 00976/73 A YU00976/73 A YU 00976/73A YU 97673 A YU97673 A YU 97673A YU 97673 A YU97673 A YU 97673A
Authority
YU
Yugoslavia
Prior art keywords
phenetyl
dihydroxy
amines
beta
obtaining substituted
Prior art date
Application number
YU00976/73A
Other versions
YU36483B (en
Inventor
Tuttle Ronald Ralph
Ronald Ralph Tuttle
Mills Jack
Jack Mills
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU97673(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of YU97673A publication Critical patent/YU97673A/en
Publication of YU36483B publication Critical patent/YU36483B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU00976/73A 1972-04-12 1973-04-11 Process for obtaining substituted 3,4-dihydroxy-beta-phenetyl amines YU36483B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (2)

Publication Number Publication Date
YU97673A true YU97673A (en) 1982-02-25
YU36483B YU36483B (en) 1984-02-29

Family

ID=22918877

Family Applications (2)

Application Number Title Priority Date Filing Date
YU00976/73A YU36483B (en) 1972-04-12 1973-04-11 Process for obtaining substituted 3,4-dihydroxy-beta-phenetyl amines
YU3212/79A YU37113B (en) 1972-04-12 1979-12-28 Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU3212/79A YU37113B (en) 1972-04-12 1979-12-28 Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine

Country Status (31)

Country Link
JP (2) JPS5825656B2 (en)
KR (1) KR790000113B1 (en)
AR (1) AR203822A1 (en)
AT (1) AT323719B (en)
AU (1) AU472734B2 (en)
BE (1) BE798051A (en)
BG (1) BG23001A3 (en)
CA (1) CA1018188A (en)
CH (2) CH569691A5 (en)
CS (2) CS190448B2 (en)
CY (1) CY963A (en)
DD (1) DD107670B3 (en)
DE (1) DE2317710C2 (en)
DK (1) DK142750C (en)
ES (1) ES413639A1 (en)
FR (1) FR2182947B1 (en)
GB (1) GB1392674A (en)
HK (1) HK50178A (en)
HU (2) HU167597B (en)
IE (1) IE37511B1 (en)
IL (1) IL42016A (en)
KE (1) KE2870A (en)
MY (1) MY7800381A (en)
NL (1) NL174459C (en)
PH (1) PH11041A (en)
PL (2) PL90695B1 (en)
RO (2) RO65105A (en)
SE (1) SE399064B (en)
SU (1) SU496719A3 (en)
YU (2) YU36483B (en)
ZA (1) ZA732136B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (en) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
KR840000486A (en) * 1981-07-22 1984-02-22 원본미기재 Method for preparing substituted pyrrolidine
JPS6061523A (en) * 1983-09-16 1985-04-09 Shionogi & Co Ltd Oral dobutamine pharmaceutical
ZA881076B (en) * 1987-02-24 1989-10-25 Lilly Co Eli Dobutamine salts
JPH0383364U (en) * 1989-12-18 1991-08-23
WO1992020645A1 (en) * 1991-05-20 1992-11-26 Tsumura & Co. Phellodendrine analogs and allergy type iv suppressor containing the same as active ingredient
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
ATE155125T1 (en) * 1993-04-13 1997-07-15 Duphar Int Res PRODUCTION OF DOBUTAMIN COMPOUNDS
PT1546088E (en) 2002-10-03 2015-03-16 Novaremed Ltd Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
CA2560922C (en) * 2004-03-26 2014-01-07 New Era Biotech, Ltd. Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
EP2458983B1 (en) 2009-07-31 2015-07-08 Cognition Therapeutics, Inc. Inhibitors of cognitive decline
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
JP2014524482A (en) * 2011-08-25 2014-09-22 コグニション セラピューティクス，インコーポレイテッド Compositions and methods for treating neurodegenerative diseases
EP4023294A1 (en) 2014-01-31 2022-07-06 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating alzheimer's disease
BR112019023851A2 (en) 2017-05-15 2020-08-18 Cognition Therapeutics, Inc. compounds, their pharmaceutical compositions and methods for treating neurodegenerative diseases
CN114524734B (en) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 Preparation method of dobutamine hydrochloride

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
BG23001A3 (en) 1977-05-20
CY963A (en) 1978-12-22
ES413639A1 (en) 1976-01-16
KE2870A (en) 1978-09-01
CA1018188A (en) 1977-09-27
HU167597B (en) 1975-11-28
AR203822A1 (en) 1975-10-31
CH569691A5 (en) 1975-11-28
DK142750B (en) 1981-01-12
IL42016A (en) 1976-05-31
FR2182947A1 (en) 1973-12-14
BE798051A (en) 1973-10-11
FR2182947B1 (en) 1976-07-02
IE37511B1 (en) 1977-08-03
CS190448B2 (en) 1979-05-31
JPS58131945A (en) 1983-08-06
RO70892A (en) 1982-02-26
MY7800381A (en) 1978-12-31
SU496719A3 (en) 1975-12-25
GB1392674A (en) 1975-04-30
DD107670A5 (en) 1974-08-12
JPS497237A (en) 1974-01-22
ZA732136B (en) 1974-03-27
NL7305097A (en) 1973-10-16
AU5438573A (en) 1974-10-17
DE2317710C2 (en) 1983-08-04
YU37113B (en) 1984-08-31
AT323719B (en) 1975-07-25
AU472734B2 (en) 1976-06-03
PL90695B1 (en) 1977-01-31
PH11041A (en) 1977-10-25
KR790000113B1 (en) 1979-03-20
JPS6221343B2 (en) 1987-05-12
HK50178A (en) 1978-09-15
IL42016A0 (en) 1973-06-29
JPS5825656B2 (en) 1983-05-28
DE2317710A1 (en) 1973-10-18
CH580563A5 (en) 1976-10-15
CS190406B2 (en) 1979-05-31
NL174459C (en) 1984-06-18
DD107670B3 (en) 1988-04-06
NL174459B (en) 1984-01-16
SE399064B (en) 1978-01-30
DK142750C (en) 1981-08-17
PL94207B1 (en) 1977-07-30
RO65105A (en) 1980-01-15
YU36483B (en) 1984-02-29
HU166213B (en) 1975-02-28
YU321279A (en) 1983-04-27

Similar Documents

Publication Publication Date Title
YU48171A (en) Process for preparing n-(1,1,1-trisubstituted)-methylazoles
YU254979A (en) Process for preparing new 3,4-dihydrocarbostyryl-derivatives
YU36483B (en) Process for obtaining substituted 3,4-dihydroxy-beta-phenetyl amines
HU173507B (en) Process for preparing 11,15-bis-tetrahydropyranyloxy-omega-tetranor-16-phenoxy-prostaglandin derivatives
YU34884B (en) Process for preparing 1,2,3-tiadiazole derivatives
YU39297B (en) Process for preparing 6-phenyl-substituted 3-methyl-4-amino-5h-1,2,4-triazine-5-ones
YU133872A (en) Process for obtaining diphenyl-alkanoylamino-pyridines
YU35118B (en) Process for preparing n-(1-ethyl-delta-pyrrolyly-methyl)-2-methoxy-5-sulfamidobenzamide
YU292273A (en) Process for obtaining 1,2-dialkyl-3,5-diphenyl-pyrazolium salts
YU210473A (en) Process for obtaining novel oxo-3-dihydro-2,3-benzoxazine-1,4 derivatives
YU35149B (en) Process for obtaining 15 delta, 16-methylene-4-pregnene
YU229979A (en) Process for obtaining novel 1,4-benzodixane derivatives
YU318573A (en) Process for obtaining m-dioxan-5-methyl amine
KR780000156B1 (en) Process for preparing 150 160-methylen -oestren-17-36
YU35619B (en) Process for obtaining rifamycine b
YU146973A (en) Process for obtaining oxo-prostaglandins
YU36701B (en) Process for obtaining as-triazinoz5,6-ccquinoline derivatives
YU240180A (en) Process for obtaining deacetoxy-cephalosporin
YU265473A (en) Process for obtaining 7-acylamido-7-alkoxy-cephalosporins
CS191448B1 (en) Process for preparing 6,7-dihydrobenztrazole
YU34896B (en) Process for preparing substituted 2-aryla inoimidazolines-(2)
YU45373A (en) Process for preparing 6,9-dioxo-8-hydroxy-2-(3,4-dihydroxyphenyl)-bicyclo-(3,3,1)-7-nomene-3-01
YU39001B (en) Process for preparing new 3,4-dihydrocarbostyryl derivatives
YU176973A (en) New process for preparing n-(diethyl-amino-ethyl)-2-methoxy-4-amino-5-chloro-benzamides
YU242172A (en) Process for preparing n-(1-ethyl-delta-prrolidyl-methyl)-2-methoxy-5-sulfamidobenzamide